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Background: Like all diderm bacteria studied to date, Borrelia burgdorferi possesses a β-barrel assembly machine
(BAM) complex. The bacterial BAM complexes characterized thus far consist of an essential integral outer membrane
protein designated BamA and one or more accessory proteins. The accessory proteins are typically lipid-modified
proteins anchored to the inner leaflet of the outer membrane through their lipid moieties. We previously identified
and characterized the B. burgdorferi BamA protein in detail and more recently identified two lipoproteins encoded
by open reading frames bb0324 and bb0028 that associate with the borrelial BamA protein. The role(s) of the BAM
accessory lipoproteins in B. burgdorferi is currently unknown.
Results: Structural modeling of B. burgdorferi BB0028 revealed a distinct β-propeller fold similar to the known
structure for the E. coli BAM accessory lipoprotein BamB. Additionally, the structural model for BB0324 was
highly similar to the known structure of BamD, which is consistent with the prior finding that BB0324 contains
tetratricopeptide repeat regions similar to other BamD orthologs. Consistent with BB0028 and BB0324 being BAM
accessory lipoproteins, mutants lacking expression of each protein were found to exhibit altered membrane
permeability and enhanced sensitivity to various antimicrobials. Additionally, BB0028 mutants also exhibited
significantly impaired in vitro growth. Finally, immunoprecipitation experiments revealed that BB0028 and BB0324
each interact specifically and independently with BamA to form the BAM complex in B. burgdorferi.
Conclusions: Combined structural studies, functional assays, and co-immunoprecipitation experiments confirmed
that BB0028 and BB0324 are the respective BamB and BamD orthologs in B. burgdorferi, and are important in
membrane integrity and/or outer membrane protein localization. The borrelial BamB and BamD proteins both
interact specifically and independently with BamA to form a tripartite BAM complex in B. burgdorferi. A working
model has been developed to further analyze outer membrane biogenesis and outer membrane protein transport
in this pathogenic spirochete.
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The pathogenic spirochetes Borrelia burgdorferi, B. garinii,
and B. afzelii are the etiologic agents of Lyme disease
[1-3]. Although B. burgdorferi possesses both a cytoplasmic
and outer membrane (OM) similar to Gram-negative bac-
teria, its OM differs significantly from the typical Gram-
negative OM in that it lacks the immunogenic glycolipid
lipopolysaccharide [4]. Instead, the borrelial OM contains
an abundant number of outer surface lipoproteins, which
have been designated Osps [5-23]. The Osps are soluble* Correspondence: darrin-akins@ouhsc.edu
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unless otherwise stated.proteins that are anchored to the bacterial surface by their
lipid moiety [6]. In addition to the numerous Osps, the
borrelial OM also contains integral outer membrane
proteins (OMPs) that contain membrane-spanning do-
mains composed of antiparallel, amphipathic β-strands
[23,24]. Presently, only ten OMPs have been identified
in B. burgdorferi [22,25-33]. However, freeze-fracture
electron microscopy studies have revealed that there are
numerous OMPs present in the borrelial OM [24].
Therefore, it is likely that the ten known OMPs only
represent a small subset and many have likely not yet
been identified. Identification and characterization of novelhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in the field because they may represent novel vaccine
candidates.
Exactly how OMPs are folded and inserted into the
OM of bacteria is an active area of research [34-43].
While it has been shown that bacterial OMPs (e.g.,
OmpA, PagP, OmpX, FadL, OmpLA) can spontaneously
fold into their native conformation and incorporate into
synthetic lipid bilayers and/or detergent micelles in vitro
[44-47], recent studies have revealed that the lipid com-
position of bacterial OMs does not readily allow for
spontaneous insertion of most OMPs [39]. To overcome
this kinetic barrier of insertion in vivo, bacteria require
the β-barrel assembly machine (BAM) complex [39].
The BAM complex is composed of an essential BamA
protein and one or more accessory proteins [34,48-51].
BamA is an OMP itself that contains an N-terminal
periplasmic region with five polypeptide transport-asso-
ciated (POTRA) domains. POTRA domains are all com-
posed of a highly similar β-α-α-β-β structural motif
[35,36] and are important for the interaction between
BamA and BAM accessory lipoproteins [52,53]. In E. coli,
there are four BAM complex accessory lipoproteins: BamB,
C, D, and E. BamB and BamD specifically interact with the
BamA POTRA domains, while BamC and BamE associate
with the larger complex by interacting with BamD
[48-50,54,55]. All BAM complexes characterized to date
have been shown to be essential for bacterial survival
[56-58] due to the critical role they play in OM biogenesis
and OMP transport [51,59,60].
While all BAM complexes contain a BamA protein,
the accessory lipoproteins can vary greatly in number
and overall sequence among different bacterial groups
[49,51,53,61-65]. For instance, most β- and γ-proteobac-
teria typically possess four accessory proteins: BamB, C,
D, and E [50,63,66]. In contrast, only BamD orthologs
have been identified thus far in the δ- and ε-proteobac-
teria [49]. We previously reported that the BAM complex
in B. burgdorferi is comprised of a BamA ortholog and
two putative lipoproteins designated BB0324 and BB0028,
with BB0324 being suggested to be a BamD ortholog
[25,67]. To further these prior analyses, we have used
structural studies, functional assays, and co-immunopre-
cipitation experiments to generate a refined topological
model of the B. burgdorferi BamA protein and to examine
the roles of BB0028 and BB0324 in the borrelial BAM
complex. The combined studies revealed that BB0028
and BB0324 play a role in membrane integrity and/or
OMP localization, which is consistent with BB0028
and BB0324 being BamB and BamD orthologs, respect-
ively. A working model is proposed for the borrelial
BAM complex that can now be used to further explore
OM biogenesis and OMP transport in this pathogenic
spirochete.Results
Structural model of the B. burgdorferi BamA protein
The B. burgdorferi β-barrel assembly machine (BAM)
complex appears to be comprised of three proteins: the
integral outer membrane protein (OMP) BamA and two
accessory lipoproteins designated BB0028 and BamD/
BB0324 [25,67]. While there is little information regarding
the structure or function of the borrelial accessory lipo-
proteins, the BamA protein was previously examined
using two different structural modeling algorithms to pre-
dict the topology of the membrane-spanning C-terminal
domain and the conformation of the N-terminal periplas-
mic region [25]. The recently determined crystal structure
of N. gonorrhoeae BamA [36], however, provided a known
template to refine the structural prediction of the borrelial
BamA protein using the I-TASSER protein structure
prediction algorithm [68-70]. As shown in Figure 1A, the
model predicted for B. burgdorferi BamA was observed
to be highly similar to N. gonorrhoeae BamA, and the
confidence score (C-score) for the predicted model was
0.55. The C-score is the most pertinent score for
assessing model quality and can range from −5 to +2,
with scores > −1.5 considered to accurately indicate the
final secondary structure conformation [70]. The I-TASSER
server also provides a template modeling score (TM-score)
to assess the overall structural similarity between the pre-
dicted model and the known template structure (TM-
score > 0.5 indicates correct topology prediction). The
TM-score for the borrelial BamA model was 0.79 ± 0.09.
Combined, the C-score and TM-score indicate that the
newly-refined model generated for B. burgdorferi BamA is
of high quality.
The modeled structure depicted in Figure 1A (left)
indicates that B. burgdorferi BamA consists of a N-
terminal periplasmic domain containing five polypep-
tide transport-associated (POTRA) motifs followed by
a β-barrel domain with 16 membrane-spanning β-strands.
A conserved α-helical region was identified in extracellu-
lar loop four, which has also been noted in all BamA
structures characterized to date [35,36]. Additionally, loop
six contains an arginine-glycine-tryptophan triad that may
correspond to the RGF motif found in the same loop of
other BamA proteins, which has been shown to be essen-
tial for BamA function [43,71-73] (Figure 1B). To further
examine the reliability of the model generated, we next
inserted a c-Myc tag into predicted extracellular loop
three (Figure 1B; c-Myc insert shown in green). As shown
in Figure 1C, surface immunofluorescence assays using
c-Myc-specific antibodies verified that the c-Myc tag, as
predicted, was located on the borrelial surface, which is
entirely consistent with the structural model predicted
by I-TASSER. As expected, the wildtype strain lacking a
c-Myc tag displayed no reactivity with the c-Myc anti-
bodies. To ensure that the fragile outer membrane of
Figure 1 Proposed structural model of B. burgdorferi BamA. A. The predicted structure of the B. burgdorferi BamA protein (left) determined
using the I-TASSER algorithm [68-70] compared to the structure of BamA from N. gonorrhoeae (right). Predicted β-sheet regions are depicted in
yellow and α-helical regions are depicted in red. B. Diagram of the β-barrel domain of the B. burgdorferi BamA protein with predicted extracellular
loops numbered. The location of the c-Myc tag (EQKLISEEDL) insertion site in extracellular loop three is indicated in green. The site of the
predicted α-helical region in extracellular loop four is indicated in red and the blue region within extracellular loop six indicates the position of
the conserved RGF motif. OM; outer membrane. C. The c-Myc tag inserted in predicted loop three (BamA::c-Myc) was examined using surface
immunofluorescence assays and antibodies to c-Myc or the periplasmic FlaB protein (top; two leftmost panels). The DNA-specific dye DAPI was
also used to identify all organisms in a given microscopic field (top; third panel from left). As a control for the surface specificity, organisms also
were fixed to slides before incubation with the c-Myc and FlaB antibodies (fixed panels). The parental, wildtype strain was also subjected to the
same assays (bottom panels).
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for the periplasmic FlaB protein were also included in
the surface localization experiments. When anti-FlaB
antibodies were co-incubated with the anti-cMyc anti-
bodies, no FlaB was identified, indicating that the
outer membranes were intact (Figure 1C; panels sec-
ond from left). The DNA-binding dye DAPI was also
included in the mounting media for all immunofluor-
escence experiments to help identify all spirochetes in
a given microscopic field. As a control for FlaB re-
activity, organisms also were dried to slides and fixed
with acetone to disrupt the outer membranes before
co-incubation with the FlaB and c-Myc antibodies, asshown in the rightmost panels of Figure 1C. As expected,
the fixed organisms fluoresced brightly with the FlaB
antibodies.
Structural models of the B. burgdorferi BAM accessory
lipoproteins
The B. burgdorferi BamA protein has been shown to co-
immunoprecipitate with two accessory lipoproteins,
encoded by open reading frames bb0028 and bb0324 [67].
BB0324 was previously shown to share significant similar-
ity with the N-terminus of BamD from N. meningitidis
and to contain tetratricopeptide repeat (TPR) domains.
TPR domains are antiparallel α-helices commonly involved
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quence similarity between BB0324 and other known
BamD proteins suggested BB0324 is a putative BamD
ortholog [67]. BB0028, however, shares no sequence
similarity with any of the known or putative BAM ac-
cessory proteins. When the I-TASSER algorithm [68-70]
was used to model BamD/BB0324 without a specified
template, the structure predicted consisted of five stacked
α-helical domains (Figure 2A; left). This predicted structure
was highly similar to the N-terminal region of the known
E. coli BamD structure [75,76] (Figure 2A; right). BB0028
was predicted by I-TASSER to fold into a β-propeller
structure (Figure 2B; left), which is the known conformation
of the E. coli BamB protein [52,55,77] (Figure 2B; right).Figure 2 Structural models of BamD/BB0324 and BB0028. Structural m
shown in yellow and α-helical regions shown in red. A. Predicted structure
of the E. coli BamD protein (right). B. Predicted structure of B. burgdorferi BB
protein (right).Generation of B. burgdorferi BamD/BB0324 and BB0028
mutants
While prior co-immunoprecipitation experiments [67]
combined with the structural modeling outlined above
suggest BamD/BB0324 and BB0028 are members of the
borrelial BAM complex, neither of these approaches
provided empirical evidence that they are functional com-
ponents of the BAM complex in B. burgdorferi. Therefore,
to determine if BamD/BB0324 and/or BB0028 function as
would be expected of BAM complex accessory proteins,
we generated BamD/BB0324 and BB0028 mutants as de-
scribed in the Methods section. As shown in Figure 3A,
bamD/bb0324 was deleted and replaced by a streptomycin
resistance cassette using homologous recombination. Theodeling using the I-TASSER algorithm with predicted β-sheet regions
of B. burgdorferi BamD/BB0324 (left) compared to the known structure
0028 (left) compared to the known structure of the E. coli BamB
Figure 3 Generation of a bamD/bb0324 mutant. A. A bamD/bb0324 mutant was generated through homologous recombination by replacing
the bamD/bb0324 gene with a streptomycin resistance cassette. Red arrows indicate primers used to confirm insertion of the streptomycin
cassette in the borrelial genome. B. PCR amplification resulted in a 1.4 kb amplicon in the wildtype strain while the BamD/BB0324 mutant
containing the streptomycin cassette produced a 2.4 kb amplicon, as expected. A PCR reaction with no DNA template (Neg) was included as a
negative control. DNA sizes, in kilobase pairs, are indicated at left. C. Whole-cell lysate from the BamD/BB0324 mutant (BamD::strepR) and parental
(WT) strains were subjected to immunoblot analysis using BamD/BB0324 specific antibodies (top panel). FlaB antisera was used to ensure equal
loading of lysates examined (bottom panel).
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firmed by PCR analyses using primers flanking bamD/
bb0324 (Figure 3B). Immunoblot with BamD/BB0324 spe-
cific antisera confirmed that the BamD mutant strain, des-
ignated BamD::strepR, did not express BamD, as expected
(Figure 3C). Numerous attempts to delete bb0028 through
homologous recombination were unsuccessful, which sug-
gested BB0028 may be essential for in vitro cultivation of
B. burgdorferi. To overcome this potential caveat, we
generated an IPTG-regulatable mutant of BB0028 by
expressing the native bb0028 gene under control of the
IPTG-inducible flacp promoter (Figure 4A). The resulting
strain was confirmed by PCR to contain the streptomycin
resistance cassette/flacp promoter construct (Figure 4B),
and regulation of BB0028 by IPTG was confirmed by
immunoblot analysis using polyclonal, monospecific rat
anti-BB0028 antibodies (Figure 4C).
Interestingly, the BB0028 regulatable mutant was ob-
served to replicate in vitro without addition of IPTG in
the growth media (Figure 4C), although it should be
noted that the organisms were qualitatively less motile
when examined under the microscope and replicated ata much slower rate as compared to wildtype organisms
expressing normal amounts of BB0028. This observation
suggested that BB0028, while not absolutely essential for
in vitro cultivation of the organism, may be relevant to
the overall growth and physiology of B. burgdorferi.
To more quantitatively examine these observations,
we next examined the growth rate of the BB0028 mutant
in vitro, which revealed that the doubling time of the mu-
tant was 14 h, while the parental strain had a doubling
time of only 8 h. The BB0028 mutant also required 72–96
hours longer to reach stationary phase as compared to the
wildtype parental strain (Figure 5A). To ensure that the
ability of the BB0028 mutant to grow in the absence of
IPTG was not the result of a secondary mutation in the
lacI gene or flacp promoter that allowed the mutant to ex-
press BB0028, we performed immunoblot analyses which
confirmed that BB0028 was not expressed in the mutant
strain during cultivation (Figure 5A; inset). When similar
growth curve analyses were performed on the BamD/
BB0324 mutant strain, no impact on the rate of in vitro
growth was observed as compared with the parental strain
(Figure 5B).
Figure 4 Generation of a bb0028 mutant. A. An IPTG-regulatable bb0028 mutant was generated by inserting a streptomycin resistance cassette
followed by the flacp promoter immediately upstream of bb0028. Red arrows indicate primer-binding areas used to confirm insertion of the
streptomycin cassette and flacp promoter into the borrelial genome. B. PCR amplification resulted in a 1.2 kb amplicon in the wildtype strain
(WT), as expected, and a 3.0 kb amplicon in the BB0028 mutant (flacp::0028) indicating the streptomycin cassette and flacp promoter were
inserted in the mutant. A PCR reaction with no DNA template (Neg) was included as a negative control. DNA sizes, in kilobase pairs, are indicated
at left. C. Whole-cell lysate from the BB0028 mutant (flacp::0028) strain propagated with (+) or without (−) 1 mM IPTG, as well as from the parental,
wildtype strain (WT), were subjected to immunoblot analysis using BB0028 specific antibodies (top panel) or FlaB antibodies (bottom panel).
FlaB reactivity was used to ensure all lanes were loaded equally.
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sensitivity
In Gram-negative bacteria, mutants lacking various BAM
accessory proteins have altered outer membrane (OM)
permeability and sensitivity profiles to antimicrobials
[64,78,79]. Therefore, we examined whether the absence
of the B. burgdorferi BAM accessory proteins BB0028
or BamD/BB0324 affected susceptibility to antimicrobial
agents. To determine the minimum inhibitory concen-
tration of specific antimicrobials, the respective parental
wildtype and mutant strains were cultivated in media con-
taining varying concentrations of carbenicillin, cefotaxime,
tetracycline, or minocycline. As shown in Table 1, when
compared to the wildtype B31-A3-LK strain, the suscepti-
bility of the BB0028 mutant (flacp::BB0028) to carbenicillin
increased by two-fold, and susceptibility to tetracyclineincreased by four-fold. The BamD/BB0324 mutant
(BamD::strepR) also exhibited altered susceptibility; it was
observed to be two-fold and eight-fold more susceptible
to tetracycline and minocycline, respectively, as com-
pared to the parental B31-5A4NP1 strain. We also ex-
amined the susceptibility profile of the B. burgdorferi
IPTG-regulatable BamA mutant [25] as a control. Redu-
cing BamA expression using limiting amounts of IPTG in
the regulatable BamA mutant (flacp::BamA) resulted in in-
creased susceptibility to all antibiotics tested, as expected,
with a four-fold increase in susceptibility to carbenicillin
and two-fold increases to cefotaxime, tetracycline, and
minocycline, as compared to the parental strain B31-
A3-LK. Taken together, these results suggest that both
BB0028 and BamD/BB0324 play important, although pos-
sibly different, roles in OM composition and/or integrity.
Figure 5 The BB0028 mutant exhibits impaired growth in vitro. A. Growth rate analysis of the parental strain (■) and BB0028 mutant strain
(▲). The BB0028 mutant required 3–4 more days to reach stationary phase than the parental strain. The inset confirms by immunoblot that
BB0028 was not expressed by the BB0028 mutant (▲) during culture. As a control, the wildtype, parental strain (■) was also immunoblotted for
BB0028. Lysates also were probed with FlaB specific antibodies to confirm equivalent loading. B. Growth rate comparison of the wildtype (■) and
BamD/BB0324 mutant (▲) strains.
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the BB0028 mutant
To examine the underlying causes for the enhanced sus-
ceptibility of the different mutants to antimicrobial
agents, we next examined whether the presence of the
OMP BesC was altered in the OM of the BB0028 or
BamD/BB0324 mutant strains. BesC is the outer mem-
brane protein component of a known B. burgdorferi
multidrug efflux complex that is involved in enhancing
resistance to various antimicrobials [27]. We therefore
performed immunoblot analysis on isolated OM fractionsto examine the level of BesC exported into the OM of the
BB0028 and BamD/BB0324 mutant strains. Interest-
ingly, when equal amounts of the isolated OM frac-
tions were compared, there was a marked decrease in the
amount of BesC located in the OM of the BB0028 mutant
as compared to its parental wildtype strain (Figure 6A;
BesC OM panels). By contrast, no observable decrease in
BesC was detected in the OM fraction of the BamD mu-
tant strain as compared to its wildtype parental strain
(Figure 6B; BesC OM panels). The overall expression of
BesC and its export to the inner membrane also did not
Table 1 Absence of BamA, BB0028, or BamD/BB0324
affects antimicrobial sensitivity
Minimum inhibitory concentration (ng/ml)a
(Fold change susceptibility)b
Carbenicillin Cefotaxime Tetracycline Minocycline
flacp::BB0028c 156 (2X) 20 78 (4X) 78
BamD::strepR 313 39 39 (2X) 10 (8X)
flacp::BamAd 78 (4X) 10 (2X) 156 (2X) 39 (2X)
B31-A3-LK 313 20 313 78
B31-5A4NP1 313 39 78 78
a – All MIC assays were performed in triplicate.
b – flacp::BB0028 and flacp::BamA are compared with strain B31-A3-LK; BamD::
strepR is compared with strain B31-5A4NP1.
c – flacp::BB0028 was grown in media without added IPTG.
d – flacp::BamA was grown in media containing 0.05 mM IPTG.
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BesC levels in the protoplasmic cylinder (PC) fractions
were comparable between BB0028 and BamD/BB0324
mutants and their respective parental strains (Figure 6A
and B; BesC PC panels). As shown in Figure 6A (BamD
panels) and Figure 6B (BB0028 panels), BB0028 and
BamD/BB0324 expression levels and OM localization
were not affected by the absence of BamD/BB0324 or
BB0028, respectively. Membranes were also immunoblotted
with antisera to CspA, an OM-localized lipoprotein, to en-
sure equivalent amounts of PC and OM fractions were
loaded for the immunoblot analyses (Figure 6A and B;
CspA panels). Finally, OppAIV, a known inner membrane
lipoprotein, was used to confirm that the OM fractions
were highly purified and devoid of contaminating PC
components (Figure 6A and B; OppAIV panels). The
combined analyses indicate that BesC export into the OM
of B. burgdorferi is diminished in the BB0028 mutant but
not in the BamD/BB0324 mutant.Figure 6 Absence of BB0028 results in decreased BesC in the B. burgd
fractions were isolated from the BB0028 mutant (LKflacp::0028) and parenta
BesC, BamD/BB0324, CspA, and OppAIV. B. OM and PC fractions were isola
wildtype (WT) strain and immunoblotted with antibodies specific for BesC,BamA independently interacts with BB0028 and BamD/
BB0324
We have previously shown that BamA co-immunoprecipi-
tates BamD/BB0324 and BB0028 [67]. These prior studies,
however, did not examine whether BamD/BB0324 and
BB0028 interact independently with BamA or if they actu-
ally interact with each other as a module and only BB0028
or BamD/BB0324 interacts in a specific manner with
BamA. Therefore, as shown in Figure 7A, we performed
co-immunoprecipitation assays using BamA (left panel)
and BB0028 (right panel) specific antibodies in the BamD/
BB0324 mutant and wildtype strains. BamA and BB0028
could co-immunoprecipitate each other in the absence
of BamD/BB0324. Similarly, as shown in Figure 7B, co-
immunoprecipitations with BamA (left panel) and BamD/
BB0324 (right panel) specific antibodies revealed that
BamA and BamD/BB0324 could co-immunoprecipitate
each other in the absence of BB0028. The collective
co-immunoprecipitation data indicate that BB0028 and
BamD/BB0324 each independently interact with BamA.
Discussion
The BAM complex in B. burgdorferi
Currently, the predicted composition of the B. burgdorferi
β-barrel assembly machine (BAM) complex consists of
only three proteins: BamA, BB0028, and BamD/BB0324.
The combined structural and functional data presented
here are consistent with BB0028 and BB0324 being BamB
and BamD orthologs, respectively. While we previously
suggested that BB0324 is a BamD ortholog [67], the
current data fully support the new designation of BamB
for BB0028. Hereafter, we will refer to BB0028 as BamB
and BB0324 as BamD. Further, the co-immunoprecipita-
tion data revealed that the borrelial BamB and BamD lipo-
proteins interact specifically and independently with the
central BamA protein, which is also entirely consistentorferi OM. A. Outer membrane (OM) and protoplasmic cylinder (PC)
l (WT) strains for immunoblot analysis using antibodies specific for
ted from the BamD/BB0324 mutant (BamD::strepR) and its parental
BB0028, CspA, and OppAIV.
Figure 7 BB0028 and BamD/BB0324 interact independently
with BamA. A. Co-immunprecipitations of the wildtype strain (WT)
or BamD/BB0324 mutant (BamD::strepR) using antibodies specific for
BamA or BB0028 were performed and subjected to immunoblot
with antisera specific to BamA, BB0028, or BamD/BB0324. B.
Co-immunoprecipitations of the wildtype strain (WT) or BB0028
mutant (LKflacp::0028) strain were performed with antibodies specific
for BamA or BamD/BB0324 before immunoblotting with antisera
specific to BamA, BB0028, or BamD/BB0324.
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data provided in this report have led us to also propose a
new working model for the B. burgdorferi BAM complex
where BamD and BamB each interact directly and inde-
pendently with the BamA protein (Figure 8). Future stud-
ies will be needed to fully dissect the specific interactions
between BamB and BamD with the periplasmic polypep-
tide transport-associated (POTRA) domains of BamA in
B. burgdorferi.
Structural models for the B. burgdorferi BamA, BamB, and
BamD proteins
The recent crystal structures of BamA from N. gonor-
rhoeae, H. ducreyi, and E. coli [35,36] allowed us to re-
fine the prior model of the borrelial BamA protein [25].While all three of these structures are highly conserved,
there is only between 49-62% similarity between the
N. gonorrhoeae, H. ducreyi, and E. coli BamA proteins.
This indicates that while the BamA proteins from different
organisms are highly conserved at the three-dimensional
level, they are quite divergent at the primary sequence
level. For example, the N. gonorrhoeae BamA protein
shares between 29-52% sequence similarity to BamA or-
thologs from other bacterial phyla. Accordingly, B. burg-
dorferi BamA is 33% similar to N. gonorrhoeae BamA but
was predicted to be highly conserved structurally. The
model predicted for B. burgdorferi BamA contains a C-
terminal β-barrel region consisting of 16 transmembrane
domains and five POTRA domains along with a unique
α-helical region within extracellular loop four, which is
a conserved feature that has been identified in all BamA
crystal structures reported to date [35,36]. Extracellular
loop six in B. burgdorferi was predicted to be elongated
and associated with the lumen of the protein, which is
also similar to the known BamA structures [35,36].
Additionally, as recently highlighted by Albrecht and
co-workers [35], extracellular loop six of all known
BamA structures contains a conserved three amino acid
arginine-glycine-phenylalanine/tyrosine triad, referred
to as the RGF motif, which has been shown to be essen-
tial for BamA function [43,71-73]. Interestingly, extra-
cellular loop six in the predicted B. burgdorferi BamA
structure was observed to contain an RGW triad, which
is consistent with it corresponding to the RGF motif
given that the R and G are identical and the third amino
acid is aromatic (W) like in all other RGF motifs identi-
fied to date [72]. Future site-directed mutational studies
will be required to determine if this RGW triad plays an
important role in B. burgdorferi BAM function.
Structural modeling of the borrelial accessory lipopro-
teins revealed that the BamB protein folds into a β-
propeller, which is a structure conserved among all
BamB orthologs [54,77,80]. This structural conserva-
tion, combined with its specific interaction with BamA,
is consistent with the conclusion that BB0028 is the bor-
relial BamB ortholog. The B. burgdorferi BamD protein
was predicted to form a helix-loop-helix structure consist-
ing of five α-helices stacked on top of each other. This
same type of folding and helix stacking is also found in
the solved structures of the BamD orthologs from E. coli
and Rhodothermus marinus [49,75,76]. Interestingly, the
BamD ortholog in B. burgdorferi is C-terminally truncated
and is half the size, or less, compared with other BamD
orthologs [51,75]. The C-terminal portion of BamD has
previously been reported to be integral to mediating the
interaction between BamD and BamC in E. coli [81]. The
apparent lack of a BamC ortholog in B. burgdorferi would
be consistent with the C-terminal region of BamD being
dispensable in B. burgdorferi. This finding also further
Figure 8 Current structural model of the tripartite B. burgdorferi BAM complex. The BAM complex in B. burgdorferi deduced from the
combined structural models and co-immunoprecipitation data. The accessory lipoproteins BamD (BB0324, blue) and BamB (BB0028, purple)
interact independently with the periplasmic POTRA domains of BamA (BB0795, green).
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feri is limited to BamA, BamB, and BamD.
Functional roles of BamB and BamD in B. burgdorferi
While we were able to generate a bamD null mutant, we
were initially unable to generate a bamB knockout. To
overcome this obstacle, we utilized an IPTG-regulatable
promoter system to control expression of BamB so we
could examine the role of BamB in the borrelial BAM
complex. Interestingly, the BamB regulatable mutant
grew in the absence of IPTG and was shown to lack
BamB protein expression. This finding suggests BamB is
not essential, at least for in vitro growth, in B. burgdor-
feri. Lack of BamB expression, however, did impact the
overall physiology of the organism as the BamB mutant
had a doubling time 75% greater than that of the paren-
tal strain. While the BamB null mutant had a marked
growth phenotype, which is similar to what has been ob-
served in an E. coli BamB mutant [79], it was surprising
that the borrelial BamD mutant had no observable
growth defect given that BamD orthologs have been
reported to be essential in all bacteria studied to date
[51,78,81] other than Salmonella enteritidis [66]. In the
case of S. enteritidis, however, while BamD is not essen-
tial, the null mutant has a substantially compromised
growth rate and reduced viability as compared to theparental strain [66]. Additionally, S. enteritidis BamD
mutants show reduced amounts of export of OmpA into
their OMs [66]. Given that B. burgdorferi has at least
10-fold fewer OMPs relative to surface area than the
typical Gram-negative organism, this may suggest that
the role of BamD is unique in this spirochete [24].
Future studies examining OMP export in the BamD
mutant will be required to better understand the role
of BamD in the borrelial BAM complex, OMP export,
and OM permeability/integrity.
BAM accessory protein mutants have been shown to
have altered membrane integrity and/or impaired export
of OMPs in other organisms studied [51,64,78,79]. Con-
sistent with this latter observation, we also observed a
distinct decrease in the amount of BesC exported into
the OM of the BamB mutant, which could explain the
differing antibiotic susceptibility profiles observed between
the BamB and BamD mutants. The antibiotics we utilized
for susceptibility testing typically enter the bacterial cell
either through aqueous channels such as porins (i.e.,
carbenicillin, cefotaxime, and tetracycline) or by travers-
ing the lipid bilayer (i.e., minocycline) [82,83]. Given
that BesC can form channels in lipid bilayers [27], it is
tempting to speculate that the reduction in the OM of
BesC in the BamB mutant correlates with increased sus-
ceptibility to the pore-transiting antibiotics carbenicillin
Dunn et al. BMC Microbiology  (2015) 15:70 Page 11 of 16and tetracycline. By contrast, the BamD mutant was eight-
fold more susceptible to the membrane permeable
antibiotic minocycline as compared to the BamB mutant,
suggesting that membrane integrity is altered in the BamD
mutant, which could lead to enhanced diffusion of this
hydrophobic antibiotic across the OM. While future
studies will be required to better examine global effects
of BamB and BamD on OMP export and membrane
integrity, the antibiotic susceptibility and OMP traffick-
ing data presented here provide evidence that both of
these BAM accessory proteins play important, although
different, roles in B. burgdorferi physiology and OM
biogenesis.Conclusions
In summary, we have shown that B. burgdorferi BamA,
BamB, and BamD are predicted to be structurally very
similar to other known BamA, BamB, and BamD ortho-
logs. Through generation and characterization of BamB
and BamD mutants in B. burgdorferi, we have shown
that BamB has a major effect on physiology and growth
rate and both BamB and BamD mutants exhibit altered
sensitivity profiles to various antimicrobial compounds.
The combined results suggest that they play distinct
roles in OMP trafficking and membrane composition.
Additionally, the absence of BamB results in a decrease
in the presence of the OMP BesC in the borrelial OM,
which may account for its altered sensitivity profile to
various antibiotics, especially the more hydrophilic anti-
microbials such as carbenicillin and tetracycline. BamB
and BamD were observed to interact specifically and inde-
pendently with BamA, which led to our newly proposed
working model of the tripartite B. burgdorferi BAM com-
plex. The BAM complex model provided here lays the
foundation for future studies aimed at dissecting the inter-
action among the BAM complex components, which
should better elucidate OM biogenesis in this unique
spirochete.Methods
Bacterial strains and growth conditions
B. burgdorferi strains B31cF [84], B31cF BamA::c-
Myc, B31-A3-LK [85], B31-5A4NP1 [86], BamD::strepR,
LKflacp::BamA [25], and LKflacp::0028 were cultivated at
34°C in BSK-II medium containing 6% heat-inactivated
rabbit serum (complete BSK-II), supplemented when ap-
propriate with 200 μg/ml kanamycin, 100 μg/ml strepto-
mycin, 40 μg/ml gentamicin, and/or 1 mM or 0.05 mM
IPTG. The cloning vector pBluescript-II KS+ (Stratagene,
La Jolla, CA) and shuttle vector pBSV2 [87] were propa-
gated using E. coli strains DH5α or XL1-Blue (Stratagene)
grown in lysogeny broth (LB) or LB agar supplemented
with appropriate antibiotics.Structural modeling
BamA was modeled by the I-TASSER protein structure
and function prediction algorithm [68-70] using the
solved crystal structure of N. gonorrhoeae BamA [36] as
a template. BB0028 and BamD/BB0324 were modeled by
the I-TASSER algorithm without selection of a crystal
structure template. The resulting structural predic-
tions in .pdb format, as well as the crystal structure .pdb
files for N. gonorrhoeae BamA [PDB:4K3B], E. coli BamB
[PDB:2YH3], and E. coli BamD [PDB:2YHC], were vi-
sualized using Swiss-PdbViewer molecular visualization
software [88].
Generation of antibodies
The DNA sequence encoding BamA POTRA domains
P1-P4, plus 14 amino acids of P5, was amplified from B.
burgdorferi B31 genomic DNA using primers BamA P1
(NheI) F and BamA P4 + 14 (XhoI) R (Primers shown in
Table 2). The DNA sequence encoding mature BB0028,
lacking the N-terminal leader peptide, was amplified
from B. burgdorferi B31 genomic DNA using primers
bb0028 (NheI) F and bb0028 (XhoI) R. The bamA P1-4 +
14 and bb0028 amplicons were then cloned into NheI and
XhoI restriction sites of the the pET23a cloning vector
(EMD Millipore, Darmstadt, Germany), and the resulting
constructs were electroporated into E. coli Overexpress™
C41(DE3) (Lucigen Corp, Middleton, WI). His-tagged
BamA P1-4 + 14 and BB0028 proteins were then purified
as previously described [89,90]. Antibodies were gener-
ated against the recombinant BamA P1-4 + 14 and
BB0028 proteins by Harlan Bioproducts for Science,
Inc. (Madison, WI). Rat antibodies recognizing BamD/
BB0324, BesC, CspA, OppAIV, and FlaB were described
elsewhere [22,25,67].
Generation of B. burgdorferi mutants
The c-Myc tag was inserted into a predicted loop of the
BamA protein as follows. The first 1,581 nucleotides of
bamA (open reading frame bb0795) were amplified from
B. burgdorferi B31 genomic DNA using the primers
bb0795A (BamHI) F and bb0795A (XbaI) R and were
subsequently inserted into the shuttle vector pBSV2
using the restriction sites BamHI and XbaI. The final
860 nucleotides of bamA were then PCR-amplified using
the primers bb0795B (SalI) F and bb0795 (PstI) R and
inserted into the SalI and PstI sites of the vector construct.
The borrelial promoter flgB was then PCR-amplified
from pBSV2 using the primers flgB (BamHI) F and flgB
(BamHI) R, and the amplicon was inserted into the vector
using the restriction site BamHI. Two 48-mer oligonucle-
otides, c-Myc (XbaI-SalI) F and c-Myc (XbaI-SalI) RC,
encoding the 30-nucleotide c-Myc tag as well as 5’ XbaI
and 3’ SalI sites, were then annealed together, digested
with XbaI and SalI, and inserted into the construct. Fifteen
Table 2 Oligonucleotides used in this study
Name Sequence (5’ to 3’, restriction sites in bold) Description
BamA P1 (NheI) F GCGGCTAGCAAGGGGAAAATAATAAAGGGTAT bamA nucleotides 82–104 plus NheI site
(N-terminus of POTRA 1)
BamA P4 + 14 (XhoI) R GCGCTCGAGATTTTTATTTTTAGAAACAGTAATAG Complementary to bamA nucleotides 1079–1104
plus XhoI site (14 aa into POTRA 5 domain)
bb0028 (NheI) F GCGGCTAGCCTGCAAAAAATAAAACATGAATAC bb0028 nucleotides 109–132 plus NheI site
bb0028 (XhoI) R GCGCTCGAGTTCTTTAGTTAATTTTCTGTTTTCC Complementary to bb0028 nucleotides 1023–1047
plus XhoI site
795a (BamHI) F GCGGGATCCATGGGTTCAATTAGAGGTTTGT bamA nucleotides 1–22 plus BamHI site
795a (XbaI) R GCGTCTAGAATCAGGAACTTCCCTCTTGC Complementary to bamA nucleotides 1562–1581
plus XbaI site
795b (SalI) F GCGGTCGACCCATTTACAAGTTGGGAAGAAT bamA nucleotides 1582–1593 plus SalI site
795b (PstI) R GCGCTGCAGTCAATATCTCATCTCAATTCCTA Complementary to bamA nucleotides 1562–1581
plus XbaI site
flgB (BamHI) F GCGGGATCCTACCCGAGCTTCAAGGAAGAT flgB promoter nucleotides 1–21 plus BamHI site
flgB (BamHI) R GCGGGATCCATGGAAACCTCCCTCATTTAAA Complementary to flgB nucleotides 387–408 plus
BamHI site
c-Myc (XbaI-SalI) F GCGTCTAGAGAACAAAAACTTATTTCTGAAGAAGATCTGGTCGACGCG c-Myc tag plus 5’ XbaI and 3’ SalI sites
c-Myc (XbaI-SalI) RC GCGGTCGACCAGATCTTCTTCAGAAATAAGTTTTTGTTCTCTAGACGC Complementary to c-Myc tag plus 5’ SalI and
3’ XbaI sites
KO324 downstream (KpnI) F GCGGGTACCGATTATTTGGGCAGATATCAAG Complementary to nucleotides 330,248-330,269
of B31 chromosome (600 bp downstream of
bb0324) plus KpnI site
KO324 downstream (XhoI) R GCGCTCGAGTAATTTAAGAAATAAAAATTTTTACTG Nucleotides 329,622-329,648 of B31 chromosome
(immediately downstream of bb0324) plus XhoI site
KO324 upstream (BamHI) F GCGGGATCCTTATAGCAATAATAAGCTTATAAAG Nucleotides 328,661-328,685 of B31 chromosome
(600 bp upstream of bb0324) plus BamHI site
KO324 upstream (EcoRI) R GCGGAATTCTTCTGCCTCTTTTAGAATGTTTT Complementary to nucleotides 329,239-329,262 of
B31 chromosome (immediately upstream of
bb0324), plus EcoRI site
flgB (XhoI) F GCGCTCGAGTACCCGAGCTTCAAGGAAG flgB nucleotides 1–21 plus XhoI site
Strep (EcoRI) R GCGGAATTCTTATTTGCCGACTACCTTGGTGAT Complementary to aadA nucleotides 769–792 plus
EcoRI site
0028 F 4–29 (EcoRI&NdeI) GCGGAATTCCATATGAAACAAAAATACGAAAACTATTTTAA bb0028 nucleotides 4–29 plus EcoRI and NdeI sites
0028 R 678–699 (BamHI) GCGGGATCCACCACCAGTCATTACTAAAACT Complementary to bb0028 nucleotides 678–699
plus BamHI site
0027 F 4–29 (KpnI) GCGGGTACCAGAAAGTATATTTTTATAATACTAAT bb0027 nucleotides 4–29 plus KpnI site
0027 R 613–636 (XhoI) GCGCTCGAGCAATTTATTTACATTCACTGTAAC Complementary to bb0027 nucleotides 613–636
plus XhoI site
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into B. burgdorferi strain B31-cF and selected for on the
basis of kanamycin resistance to yield strain B31-cF
BamA::c-Myc.
The bamD/bb0324 gene was deleted in B. burgdorferi
strain B31-5A4NP1 by the following method. First, the
600-nucleotide region immediately upstream of bamD/
bb0324 was amplified from B. burgdorferi B31 genomic
DNA using the primers KO324 upstream (BamHI) F
and KO324 upstream (EcoRI) R, and cloned into the
pBluescript II KS+ cloning vector. The 600-nucleotide
region immediately downstream of bamD/bb0324 was
then amplified with primers KO324 downstream (KpnI)F and KO324 downstream (XhoI) R and inserted into
the KpnI and XhoI sites of the vector. A cassette
containing the flgB promoter and aadA streptomycin
resistance gene was then amplified from the pKFSS1
[91] plasmid using the primers flgB (XhoI) F and Strep
(EcoRI) R, and the amplicon was inserted into the vector
using XhoI and EcoRI. The final construct was then
electroporated into B. burgdorferi strain B31-5A4NP1
and selected with 100 μg/ml streptomycin to yield strain
BamD::strepR. Potential positive clones were screened by
PCR using the primers KO324 upstream (BamHI) F and
KO324 downstream (KpnI) F, and immunoblotted with
anti-BamD/BB0324 antibodies to verify the absence of
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strepR isolate was subjected to complete plasmid analysis
and was found to possess all plasmids except cp9, which
was previously shown to be absent from the parental
B31-5A4NP1 strain [86].
To generate a regulatable BB0028 mutant, the hybrid
flacp promoter [85] was inserted upstream of the bb0028
gene. Nucleotides 4–699 of bb0028 were amplified from B.
burgdorferi B31 genomic DNA using the primers 0028 F
4–29 (EcoRI&NdeI) and 0028 R 678–699 (BamHI) and
cloned into the multiple cloning site of the pBluescript II
SK+ cloning vector using the restriction sites EcoRI and
BamHI. A cassette containing the constitutive flgB pro-
moter, the aadA streptomycin-resistance gene, and the
hybrid flacp promoter was then digested from the
pTLflacp::795 construct [25] previously generated in
our laboratory and cloned into the XhoI and NdeI sites
of the vector. Finally, nucleotides 4–636 of bb0027 were
amplified using primers 0027 F 4–29 (KpnI) and 0027 R
613–636 (XhoI), and the resulting amplicon was then
inserted upstream of the streptomycin-resistance cas-
sette using the restriction enzymes KpnI and XhoI. The
final construct was subsequently electroporated into B.
burgdorferi strain B31-A3-LK and grown in the pres-
ence of 1 mM IPTG and selected with streptomycin to
yield strain LKflacp::0028. Potential positive clones were
screened by PCR using the primers 0027 F 4–29 (KpnI)
and 0028 R 678–699 (BamHI). To verify IPTG-regulation
of BB0028 from the flacp promoter, whole-cell lysates
were immunoblotted with anti-BB0028 antibodies. The
final LKflacp::0028 isolate was subjected to a complete
plasmid analysis and was found to possess all plasmids ex-
cept cp9, which was previously shown to be absent from
the parental B31-A3-LK strain [85,92,93].
Surface localization assay
B. burgdorferi strain B31-cF BamA::c-Myc and wildtype
B31-cF organisms were enumerated and diluted to a
concentration of 5 × 106 cells per ml in complete BSK-II
medium. For surface localization assays, wildtype B31-cF
and BamA::c-Myc-expressing cell suspensions were then
co-incubated with rabbit anti-c-Myc antibody (Sigma-
Aldrich, St. Louis, MO, dilution of 1:20) and rat anti-
FlaB (dilution of 1:500) for one hour. The cells were
gently pelleted at 4000 × g and washed three times with
PBS. The final pellet was resuspended in 100 μl PBS,
and 10 μl aliquots were spotted on glass slides and
allowed to air dry overnight. Slides were subsequently
fixed for 10 minutes with acetone and then blocked for
30 minutes in PBS containing 0.5% BSA. Samples were
incubated for 45 minutes with Alexa-Fluor 488-conjugated
goat anti-rabbit antibodies (1:250 dilution; Life Technolo-
gies, Grand Island, NY) and Alexa-Fluor 568-conjugated
goat anti-rat antibodies (1:500 dilution; Life Technologies).After incubation, all samples were washed three times in
blocking buffer and mounted in buffered glycerol contain-
ing 4’,6-diamidino-2-phenylindole dihydrochloride (DAPI;
Vector Laboratories, Burlingame, CA). As a control, sam-
ples were also washed, spotted onto glass slides, and fixed
with acetone prior to incubation with rabbit anti-c-Myc
antibody and rat anti-FlaB for one hour. Slides were
visualized at 1000X magnification on an Olympus BX60
fluorescent microscope (Olympus America Inc, Center
Valley, PA).
Immunoblotting
After blocking in milk buffer composed of phosphate
buffered saline, 5% nonfat dried milk, and 0.5% Tween,
polyvinylidine fluoride membranes were incubated for
one hour with rat antisera at the following dilutions
in milk buffer: 1:2000 for anti-BamA, anti-BB0028,
anti-OppAIV, and anti-BesC; 1:1000 for anti-BamD and
anti-CspA. Membranes were then washed three times,
incubated in milk buffer with a 1:10,000 dilution of HRP-
conjugated goat anti-rat antibodies (Bio-Rad, Hercules,
CA), and washed three additional times. Immunoblots were
developed by enhanced chemiluminescence (Amersham
Biosciences, Piscataway, NJ).
Growth assays
Triplicate 14 ml cultures were seeded at 3000 Borrelia/
ml and grown at 34°C in complete BSK-II containing
appropriate antibiotics and IPTG as necessary. Cultures
were then enumerated at 24-hour intervals by dark field
microscopy until reaching stationary phase, and the
mean Borrelia/ml were plotted for each strain at each
time point. To ensure appropriate IPTG regulation of
BB0028 at all phases of growth, samples of the LK and
LKflacp::0028 strains were taken at mid-log (approx. 1 ×
107 Borrelia/ml; day 4 for LK, day 6 for LKflacp::0028)
and stationary (day 6 for LK, day 10 for LKflacp::0028)
phases, and whole-cell lysates were prepared and immu-
noblotted with rat BB0028 antibodies. Standard devi-
ation for each timepoint was determined and is shown
by error bars in Figure 5.
Antimicrobial susceptibility assays
Antimicrobial susceptibility was determined by a method
adapted from Bunikis, et al. and Hunfeld, et al. [27,94].
Antimicrobial agents were serially diluted in a 96-well
microtiter plate in a volume of 100 μl complete BSK-II
per well. Each well was then inoculated with 100 μl of
complete BSK-II media containing strain-specific antibi-
otics and IPTG, if necessary, and 5 × 107 Borrelia/ml,
for a final cell density of 2.5 × 107 Borrelia/ml. The
concentration ranges for each antimicrobial agent tested
were as follows (ng/ml): carbenicillin 2–5000; cefotaxime
5–10,000; tetracycline 5–10,000; and minocycline 5–10,000.
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for 72 hours at 34°C with 5% CO2. At 0-, 24-, 48-, and 72-
hour timepoints, the absorbance of each well was mea-
sured at 562 nm and 630 nm using a Molecular Devices
SpectraMax 340 plate reader (Molecular Devices, Sunny-
vale, CA). Each assay was repeated in triplicate, and the
mean 562/630 nm ratio, corresponding to the amount of
growth in each well, for each concentration of each anti-
microbial agent was then plotted with respect to time to
determine the minimum inhibitory concentration of each
antibiotic.Isolation of B. burgdorferi OM vesicles
B. burgdorferi outer membrane (OM) and protoplasmic
cylinder (PC) fractions were isolated as previously de-
scribed [25,95,96]. Equivalent amounts of OM and PC
fractions were then separated by SDS-PAGE and immu-
noblotted with appropriate antibodies. To ensure equiva-
lent loading of OM and PC fractions, membranes were
immunoblotted for the OM lipoprotein CspA [22,97]. To
ensure proper fractionation of OM and PC fractions,
membranes were also immunoblotted for the lipoprotein
OppAIV, which is known to localize to the inner mem-
brane [96,98].Co-immunoprecipitation
Lysates of B. burgdorferi strains B31-5A4NP1, BamD::
strepR, B31-A3-LK, and LKflacp::0028 were prepared for
co-immunoprecipitation studies as previously described
[67]. Co-immunoprecipitation was performed according
to manufacturer’s protocol using the Pierce Crosslink
Immunoprecipitation Kit (Pierce Biotechnologies, Rock-
ford, IL). Briefly, 250 μl lysate from each strain was pre-
cleared and then applied in IP/Lysis Buffer to Protein A/
G columns treated and crosslinked with 10 μl of anti-
serum to BamA, BB0028, or BamD. After incubation at
4°C for 3 hours, columns were washed and the bound
protein was eluted in low pH elution buffer for later
analysis by SDS-PAGE and immunoblotting.
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